Literature DB >> 20058243

Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release.

P C Bessa1, E R Balmayor, H S Azevedo, S Nürnberger, M Casal, M van Griensven, R L Reis, H Redl.   

Abstract

Bone morphogenetic proteins (BMPs) are cytokines with strong ability to promote new bone formation. Herein, we report the use of silk fibroin microparticles as carriers for the delivery of BMP-2, BMP-9 or BMP-14. BMP-containing fibroin microparticles were prepared by a mild methodology using dropwise addition of ethanol, exhibiting mean diameters of 2.7 +/- 0.3 microm. Encapsulation efficiencies varied between 67.9 +/- 6.1 % and 97.7 +/- 2.0 % depending on the type and the amount of BMP loaded. Release kinetics showed that BMP-2, BMP-9 and BMP-14 were released in two phases profile, with a burst release in the first two days followed by a slower release, for a period of 14 days. The release data were best explained by Korsmeyer's model and the Fickian model of drug diffusion. Silk fibroin microparticles can offer a promising approach for the sustained delivery of different BMPs in tissue engineering applications. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20058243     DOI: 10.1002/term.245

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  18 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

Review 2.  Silk-based delivery systems of bioactive molecules.

Authors:  Keiji Numata; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2010-03-16       Impact factor: 15.470

3.  Bioactivity of porous biphasic calcium phosphate enhanced by recombinant human bone morphogenetic protein 2/silk fibroin microsphere.

Authors:  Liang Chen; Yong Gu; Yu Feng; Xue-Song Zhu; Chun-Zeng Wang; Hai-Long Liu; Hai-Yun Niu; Chi Zhang; Hui-Lin Yang
Journal:  J Mater Sci Mater Med       Date:  2014-07       Impact factor: 3.896

4.  Lumbar interbody fusion with porous biphasic calcium phosphate enhanced by recombinant bone morphogenetic protein-2/silk fibroin sustained-released microsphere: an experimental study on sheep model.

Authors:  Liang Chen; Hai-Long Liu; Yong Gu; Yu Feng; Hui-Lin Yang
Journal:  J Mater Sci Mater Med       Date:  2015-02-18       Impact factor: 3.896

5.  A New Preparation Method for Anisotropic Silk Fibroin Nerve Guidance Conduits and Its Evaluation In Vitro and in a Rat Sciatic Nerve Defect Model.

Authors:  Andreas Herbert Teuschl; Christina Schuh; Robert Halbweis; Krisztián Pajer; Gábor Márton; Rudolf Hopf; Shorena Mosia; Dominik Rünzler; Heinz Redl; Antal Nógrádi; Thomas Hausner
Journal:  Tissue Eng Part C Methods       Date:  2015-05-18       Impact factor: 3.056

6.  Antimicrobial functionalized genetically engineered spider silk.

Authors:  Sílvia C Gomes; Isabel B Leonor; João F Mano; Rui L Reis; David L Kaplan
Journal:  Biomaterials       Date:  2011-03-31       Impact factor: 12.479

7.  Biological responses to spider silk-antibiotic fusion protein.

Authors:  Sílvia Gomes; Jabier Gallego-Llamas; Isabel B Leonor; João F Mano; Rui L Reis; David L Kaplan
Journal:  J Tissue Eng Regen Med       Date:  2011-06-29       Impact factor: 3.963

8.  A silk hydrogel-based delivery system of bone morphogenetic protein for the treatment of large bone defects.

Authors:  Tamim Diab; Eleanor M Pritchard; Brent A Uhrig; Joel D Boerckel; David L Kaplan; Robert E Guldberg
Journal:  J Mech Behav Biomed Mater       Date:  2011-11-28

Review 9.  Silk-based biomaterials for sustained drug delivery.

Authors:  Tuna Yucel; Michael L Lovett; David L Kaplan
Journal:  J Control Release       Date:  2014-06-05       Impact factor: 9.776

Review 10.  Overcoming barriers confronting application of protein therapeutics in bone fracture healing.

Authors:  Tori Czech; Moses O Oyewumi
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.